Genta, Inc (fka GNTAQ)

[sarals]

Genta drug no better than Novartis's in trial

Thu Mar 2, 2006pm ET
Company News:

Genta drug no better than Novartis's in trial
FDA accepts Genta's application for Genasense injection

Genta says cancer drug trial meets main goal

BOSTON, March 2 (Reuters) - Genta Inc. (GNTA.O: Quote, Profile, Research) said on Thursday that a mid-stage trial comparing its drug for a cancer-related condition with a drug made by Novartis AG (NOVN.VX: Quote, Profile, Research) did not show the Genta drug to be superior.

The Berkeley Heights, New Jersey-based biotechnology company said its drug, Ganite, which is approved in the United States for symptomatic patients with cancer-related hypercalcemia that is resistant to hydration, did not show a statistically significant benefit over Novartis's Aredia.

Hypercalcemia is a life-threatening condition in which calcium levels rise in the blood.

http://yahoo.reuters.com/news/articlehybrid.aspx?type=comktNews&storyid=urn:newsml:reuters.com:2...